Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes.

The Journal of clinical endocrinology and metabolism - 21 Dec 2023

Billings Liana K, Shi Zhuqing, Wei Jun, Rifkin Andrew S, Zheng S Lilly, Helfand Brian T, Ilbawi Nadim, Dunnenberger Henry M, Hulick Peter J, Qamar Arman, Xu Jianfeng

Abstract excerpt

CONTEXT: Misclassification of diabetes type occurs in people with atypical presentations of type 1 diabetes (T1D) or type 2 diabetes (T2D). Although current clinical guidelines suggest clinical variables and treatment response as ways to help differentiate diabetes type, they remain insufficient for people with atypical presentations. OBJECTIVE: This work aimed to assess the clinical utility of 2 polygenic scores...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 1
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to UK Biobank

Source

Identifiers

PMID: 37560999
DOI: 10.1210/clinem/dgad456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes.PMID 37560999Read ↗

Validation of GenProb-T1D and its clinical utility for differentiating types of diabetes in a biobank from a US healthcare system.Semantic proximity Read ↗

Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes.Semantic proximity Read ↗

Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes.Semantic proximity Read ↗

Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation.Semantic proximity Read ↗

Genetic Risk Scores for Diabetes Diagnosis and Precision MedicineSemantic proximity Read ↗

Identification Of Pathogenic Mutations And Application Of Polygenic Risk Scores In Early-Onset Diabetes PatientsSemantic proximity Read ↗

Enabling reproducible type 1 diabetes polygenic risk scoring for clinical and translational applicationsSemantic proximity Read ↗

A Polygenic Score for Type 2 Diabetes Improves Risk Stratification Beyond Current Clinical Screening Factors in an Ancestrally Diverse SampleSemantic proximity Read ↗

Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population.Semantic proximity Read ↗

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults.Semantic proximity Read ↗

Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score.Semantic proximity Read ↗

Clinical and research uses of genetic risk scores in type 1 diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.